[1]
Ibrahim, M. et al. 2025. Evaluating the Efficacy and Safety of Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. International Journal of Medical Students. 12, (Jan. 2025), S391.